What tests and treatments are included in a comprehensive STD (Sexually Transmitted Disease) panel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive STD Panel Testing Components

A comprehensive STD panel typically includes tests for syphilis, gonorrhea, chlamydia, HIV, and hepatitis B, with additional tests based on risk factors and symptoms. 1

Core STD Panel Components

Standard Tests

  • Syphilis: Serologic testing (RPR or other tests)
  • Gonorrhea: Testing for Neisseria gonorrhoeae
    • Urethral/urine specimens for all patients
    • Rectal specimens for MSM (men who have sex with men)
    • Pharyngeal specimens for MSM
  • Chlamydia: Testing for Chlamydia trachomatis
    • Urethral/urine specimens for all patients
    • Rectal specimens for MSM
    • Cervical specimens for women
  • HIV: Serologic testing
  • Hepatitis B: Surface antigen (HBsAg) testing

Additional Tests Based on Risk Assessment

  • Bacterial vaginosis: For women with symptoms or risk factors
  • Trichomoniasis: For women with symptoms
  • Herpes simplex virus: For patients with genital ulcers
  • Hepatitis C: For patients with risk factors (injection drug use, etc.)

Risk Assessment Questions

When a patient requests STD testing, the following questions should be asked to determine appropriate testing 1:

  1. Sexual history:

    • Number and gender of recent sexual partners
    • Types of sexual contact (oral, vaginal, anal)
    • Use of protection (condoms, dental dams)
    • History of previous STDs
  2. Risk factors:

    • New or multiple sexual partners
    • Partners with known STDs
    • Injection drug use
    • Sex work or partners who engage in sex work
    • Men who have sex with men
  3. Symptoms assessment:

    • Genital discharge, lesions, or rash
    • Dysuria (painful urination)
    • Pelvic or abdominal pain
    • Abnormal vaginal bleeding
    • Testicular pain or swelling

Special Considerations for High-Risk Groups

Men Who Have Sex With Men (MSM)

  • Extragenital testing is crucial - rectal and pharyngeal specimens should be collected for gonorrhea and chlamydia 2
  • Testing positivity rates are significant (3.0%-9.8%) even in asymptomatic patients 2

Pregnant Women

Pregnant women require comprehensive screening due to potential fetal impacts 1:

  • Syphilis testing in early pregnancy and possibly third trimester
  • Hepatitis B testing at first prenatal visit
  • Chlamydia and gonorrhea testing, especially for women under 25 or with risk factors
  • HIV testing at first prenatal visit
  • Bacterial vaginosis testing for those at risk for preterm labor

Common Pitfalls in STD Testing

  1. Inadequate site sampling: Failing to test extragenital sites (rectal, pharyngeal) in MSM leads to missed infections 2

  2. Overlooking asymptomatic infections: Many STDs present without symptoms but remain transmissible and can cause complications

  3. Inadequate follow-up testing: Patients with positive chlamydia should be retested 3 months after treatment to check for reinfection

  4. Not addressing partner notification: All patients with STDs should be counseled about notifying partners for testing and treatment 1

  5. Missing reportable diseases: Providers must be aware that syphilis, gonorrhea, and HIV/AIDS are reportable in all states, while chlamydia is reportable in most states 1

By following these comprehensive testing guidelines, providers can effectively screen for and treat STDs, reducing transmission and preventing long-term complications that affect morbidity, mortality, and quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

STD screening of HIV-infected MSM in HIV clinics.

Sexually transmitted diseases, 2010

Related Questions

What tests and treatment are recommended for individuals at risk of or showing symptoms of sexually transmitted diseases (STDs)?
What is the standard list of labs to test for sexually transmitted diseases (STDs)?
What blood tests are typically included in sexually transmitted disease (STD) testing through a blood draw?
What blood tests should be done for a patient who had unprotected sex and wants to check for Sexually Transmitted Infections (STIs)?
What are the recommended diagnostic tests and treatment options for symptoms of vaginal discharge, odor, itching, post-intercourse pain, bleeding, and recurring infected lesions, potentially indicating a Sexually Transmitted Infection (STI)?
What are the risks and management for a 47-year-old female with a prolonged QT interval, taking lithium (lithium), duloxetine (Cymbalta) (duloxetine), and venlafaxine (Effexor) (venlafaxine)?
What is the management approach for a patient with lymphocytosis (high lymphocyte count)?
What is the best treatment approach for a 14-year-old female with Attention Deficit Hyperactivity Disorder (ADHD) and dermatillomania (skin picking disorder) with pica (eating disorder)?
How quickly should Venlafaxine (Effexor) be stopped in a patient taking 225mg of Venlafaxine (Effexor) M/R (Modified Release) with a high risk of torsades de pointes due to prolonged QTc interval?
Can GLP-1 (Glucagon-like peptide-1) receptor agonists be prescribed to patients with severe hypertriglyceridemia?
What are the primary causes of obesity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.